Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy

Globalization and Health

Juan Rivera-Dommarco¹  Armando Arredondo¹  Ruy Lopez-Ridaura¹  Carlos Aguilar-Salinas²  Ismael Campos-Nonato¹  Simon Barquera¹ 

[1] Centro de Investigación en Nutrición y Salud, Instituto Nacional de Salud Pública, Av. Universidad No. 655. Col. Sta. Ma. Ahuacatitlán, Cuernavaca, Mor, CP. 62508, Mexico, Mexico;Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, D.F, Mexico

关键词: Diabetes management;    Prevalence;    Mexico;    Costs;    Diabetes;   

Others  :  819385
DOI  :  10.1186/1744-8603-9-3

 received in 2012-07-30, accepted in 2013-01-25,  发布年份 2013

【 摘 要 】

Background

Mexico has been experiencing some of the most rapid shifts ever recorded in dietary and physical activity patterns leading to obesity. Diabetes mellitus has played a crucial role causing nearly 14% of all deaths. We wanted to make a comprehensive study of the role of diabetes in terms of burden of disease, prevalence, cost of diabetes, cost of complications and health policy.

Method

We review the quantitative data that provides evidence of the extent to which the Mexican health economy is affected by the disease and its complications. We then discuss the current situation of diabetes in Mexico with experts in the field.

Results

There was a significant increase in the prevalence of diabetes from 1994 to 2006 with rising direct costs (2006: outpatient USD$ 717,764,787, inpatient USD$ 223,581,099) and indirect costs (2005: USD$ 177,220,390), and rising costs of complications (2010: Retinopathy USD$ 10,323,421; Cardiovascular disease USD$ 12,843,134; Nephropathy USD$ 81,814,501; Neuropathy USD$ 2,760,271; Peripheral vascular disease USD$ 2,042,601). The health policy focused on screening and the creation of self-support groups across the country.

Conclusions

The increasing diabetes mortality and lack of control among diagnosed patients make quality of treatment a major concern in Mexico. The growing prevalence of childhood and adult obesity and the metabolic syndrome suggest that the situation could be even worse in the coming years. The government has reacted strongly with national actions to address the growing burden posed by diabetes. However our research suggests that the prevalence and mortality of diabetes will continue to rise in the future.

【 授权许可】

   
2013 Barquera et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Rivera JA, Barquera S, Campirano F, Campos I, Safdie M, Tovar V: Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity. Public Health Nutr 2002, 5(1a):113-122.
• [2]Barquera S, Tovar-Guzman V, Campos-Nonato I, Gonzalez-Villalpando C, Rivera-Dommarco J: Geography of diabetes mellitus mortality in Mexico: an epidemiologic transition analysis. Arch Med Res 2003, 34(5):407-414.
• [3]Barquera S, Hotz C, Rivera JA, Tolentino ML, Espinosa J, Campos I, Shamah T: Food consumption, food expenditure, anthropometric status and nutrition-related diseases in Mexico. In The double burden of malnutrition: case studies from six developing countries. Edited by Kennedy G, Nantel G, Shetty P. Rome: Food and Agriculture Organization of the United Nations; 2006:161-204.
• [4]Popkin BM: Understanding global nutrition dynamics as a step towards controlling cancer incidence. Nat Rev Cancer 2007, 7(1):61-67. 10.1038/nrc2029
• [5]Barquera S, Campirano F, Bonvecchio A, Hernandez-Barrera L, Rivera J, Popkin B: Caloric beverage consumption patterns in Mexican children. Nutr J 2010, 9(1):47. BioMed Central Full Text
• [6]Barquera S, Hernandez-Barrera L, Tolentino ML, Espinosa J, Ng SW, Rivera JA, Popkin BM: Energy intake from beverages is increasing among Mexican adolescents and adults. J Nutr 2008, 138(12):2454-2461.
• [7]Barquera S, Campos-Nonato I, Hernández-Barrera L, Flores M, Durazo-Arvizu R, Kanter R, Rivera JA: Obesity and central adiposity in Mexican adults: results from the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2009, 51:S595-S603.
• [8]Rull JA, Aguilar-Salinas CA, Rojas R, Rios-Torres JM, Gómez-Pérez FJ, Olaiz G: Epidemiology of type 2 diabetes in Mexico. Arch Med Res 2005, 36(3):188-196.
• [9]Villalpando S, de la Cruz V, Rojas R, Shamah-Levy T, Ávila MA, Gaona B, Rebollar R, Hernandez L: Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population: a probabilistic survey. Salud Publica Mex 2010, 52:S19-S26.
• [10]Veláquez M, Lara-Esqueda A, Martínez M, Márquez F: La detecció n integrada como un instrumento para vincular la prevenció n primaria, el tratamiento temprano, y la vigilancia epidemioló gica en diabetes e hipertensió n arterial. Rev Endoc Nutr 2000, 8(4):129-135.
• [11]Burke JP, Williams K, Haffner SM, Villalpando CG, Stern MP: Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care 2001, 24(9):1573-1578.
• [12]Barquera S, Campos-Nonato I, Hernández-Barrera L, Villalpando S, Rodríguez-Gilabert C, Durazo-Arvizú R, Aguilar-Salinas CA: Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010, 52:S63-S71.
• [13]Lerman I: Barreras que dificultan la aplicació n temprana de insulina en el paciente con diabetes tipo 2, Volume 7. 2nd edition. México: Asociación Latinoamericana de Diabetes; 2009:66-68.
• [14]Leyva-Flores R, Erviti-Erice J, Kageyama-Escobar ML, Arredondo A: Prescripción, acceso y gasto en medicamentos entre usuarios de servicios de salud en México. Salud Publica Mex 1998, 40:24-31.
• [15]Stevens G, Dias RH, Thomas KJA, Rivera JA, Carvalho N, Barquera S, Hill K, Ezzati M: Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med 2008, 5(6):e125.
• [16]Barquera S, Tolentino ML: La obesidad y la diabetes en México: problemas de salud pública en aumento. In En el debate: Diabetes en México. Edited by Chapela M. Mexico DF: Universidad Autónoma Metropolitana; 2010:53-84.
• [17]Durazo-Arvizu R, Barquera S, Franco M, Lazo M, Seuc A, Orduñez P, Palloni A, Cooper R: Cardiovascular diseases mortality in Cuba, Mexico, Puerto Rico and US Hispanic populations. Prev Control 2006, 2(2):63-71.
• [18]Reynoso-Noveron N, Mehta R, Almeda-Valdes P, Rojas-Martinez R, Villalpando S, Hernandez-Avila M, Aguilar-Salinas CA: Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey. Cardiovasc Diabetol 2011, 10:1. BioMed Central Full Text
• [19]Secretaría de Salud: Programa de Acción: Diabetes Mellitus. Mexico DF: Secretaría de Salud; 2001.
• [20]Secretaría de Salud: Programa Nacional de Salud 2007–2012: Por un Mé xico sano: construyendo alianzas para una mejor salud. Mexico DF: Secretaría de Salud; 2007.
• [21]Barquera S, Campos-Nonato I, Carrión-Rábago C, Villalpando S, López-Ridaura R, Rojas R, Aguilar-Salinas CA: Methodology for the analysis of type 2 diabetes, metabolic syndrome and cardiovascular disease risk indicators in the ENSANUT 2006. Salud Publica Mex 2010, 52(Suppl 1):S4-S10.
• [22]Gonzalez C, Stern MP, Gonzalez E, Rivera D, Simon J, Islas S, Haffner S: The Mexico City diabetes study: a population-based approach to the study of genetic and environmental interactions in the pathogenesis of obesity and diabetes. Nutr Rev 1999, 57(5):71-77.
• [23]Tobias M: Subnational burden of disease studies: Mexico leads the way. PLoS Med 2008, 5(6):e138.
• [24]Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP: Increased incidence of Type II Diabetes Mellitus in Mexican Americans. Diabetes Care 1991, 14(2):102-108.
• [25]Gómez-Dantés O, Garrido-Latorre F, Tirado-Gómez LL, Ramírez D, Macías C: Abastecimiento de medicamentos en unidades de primer nivel de atención de la Secretaría de Salud de México. Salud Publica Mex 2001, 43:224-232.
• [26]Rojas R, Aguilar-Salinas CA, Jiménez-Corona A, Shamah-Levy T, Rauda J, Avila-Burgos L, Villapando S, Lazcano-Ponce E: Metabolic syndrome in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010, 52(Suppl 1):S11-S18.
• [27]Hernandez-Romieu AC, Elnecave-Olaiz A, Huerta-Uribe N, Reynoso-Noveron N: Analisis de una encuesta poblacional para determinar los factores asociados al control de la diabetes mellitus en Mexico. Salud Publica Mex 2011, 53(1):34-39.
• [28]Secretaría de Salud: Diabetes mellitus: protocolo para tratamiento en las UNEMES de enfermedades crónicas. México DF: Secretaría de Salud; 2010.
• [29]Aguilar-Salinas CA, Gómez-Pérez FJ: Declaración de Acapulco: propuesta para la reducción de la incidencia de la diabetes en México. Rev Inves Clín 2006, 58:71-77.
• [30]Aguilar-Salinas C, Rull J, García E, Zúñiga S, Vázquez C, Palacios A: Consenso Mexicano para la prevención de las complicaciones crónicas de la diabetes tipo 2: avalado por la Sociedad Mexicana de Nutrición y Endocrinología, Asociación de Medicina Interna de México y la Sociedad de Nutriología. Rev Inves Clin 2010, 52:325-363.
• [31]SSA: Diabetes mellitus: Subsecretaria de Prevención y Promoción de la Salud. 1st edition. México: Secretaria de Salud, Primera edición; 2007:1-74.
• [32]Jimenez-Corona A, Rojas R, Gomez-Perez FJ, Aguilar-Salinas CA: Early-onset type 2 diabetes in a Mexican survey: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010, 52(Suppl 1):S27-S35.
• [33]Córdova-Villalobos JA, Barriguete-Meléndez JA, Lara-Esqueda A, Barquera S, Rosas-Peralta M, Hernández-Avila M, De Léon-May ME, Aguilar-Salinas CA: Las enfermedades crónicas no transmisibles en México: sinopsis epidemiológica y prevención integral. Salud Publica Mex 2008, 50(5):419-427.
• [34]Landon BE, Hicks LS, O’Malley AJ, Lieu TA, Keegan T, McNeil BJ, Guadagnoli E: Improving the management of chronic disease at community health centers. N Engl J Med 2007, 356(9):921-934.
• [35]González-Villalpando C, López-Ridaura R, Campuzano JC, González-Villalpando ME: The status of diabetes care in Mexican population: are we making a difference? Results of the National Health and Nutrition Survey 2006. Salud Publica Mex 2010, 52:S36-S43.
• [36]Renders CM, Valk GD, Griffin SJ, Wagner EH, van Eijk JT, Assendelft WJJ: Interventions to improve the management of diabetes in primary care, outpatient, and community settings. Diabetes Care 2001, 24(10):1821-1833.
• [37]See Tai S, Nazareth I, Donegan C, Haines A: Evaluation of general practice computer templates lessons from a pilot randomised controlled trial. Meth Inf Med 1999, 38:177-181.
• [38]Smith S, Bury G, O’Leary M, Shannon W, Tynan A, Staines A, Thompson C: The North Dublin randomized controlled trial of structured diabetes shared care. Fam Pract 2004, 21(1):39-45.
• [39]Secretaría de Salud: Documento base. Cinco pasos por tu Salud. Mexico DF: Secretaría de Salud; 2011.
• [40]Secretaría de Salud: Acuerdo nacional para la salud alimentaria: estrategia contra el sobrepeso y la obesidad. Mexico DF: Sub-Secretaría de Prevención y Promoción de la Salud de la Secretaría de Salud; 2010.
• [41]Secretaría de Salud: Programa de Acción Específico 2007–2012: Diabetes Mellitus. Mexico DF: Secretaría de Salud; 2007.
• [42]Sosa-Rubí SG, Galárraga O, López-Ridaura R: Diabetes treatment and control: the effect of public health insurance for the poor in Mexico. Bull World Health Organ 2009, 87:512-519.
• [43]SSA: Sistema de protección social en salud: Informe de resultados: Secretaria de Salud-Seguro Popular. 1st edition. México: Primera edición; 2010:1-93.
• [44]Arredondo A, Zúñiga A: Economic consequences of epidemiological changes in diabetes in middle-income countries. Diabetes Care 2004, 27(1):104-109.
• [45]SSA: Sistema de protección social en salud: Informe de resultados Enero-Junio: Secretaria de Salud-Seguro Popular. 3rd edition. México: Tercera edición; 2011:1-88.
• [46]Avila Burgos L, Cahuana Hurtado L, Gonzalez Dominguez D: Centro de Investigació n en Sistemas de Salud (Mexico): Cuentas en diabetes mellitus, enfermedades cardiovasculares y obesidad: Mé xico 2006. 1st edition. Cuernavaca, Morelos, Mé xico: Instituto Nacional de Salud Pú blica; 2009.
• [47]Centro de Estudios de las Finanzas Públicas de la Cámara de Diputados: Average exchange rates Mexican Peso- US Dollar 1970–2011. Mexico DF: Camara de Diputados; 2011.
• [48]Arredondo A, Recaman AL, De Icaza E: Indicadores de evaluación económica de la diabetes en México: implicaciones para el sistema de salud y la sociedad. In En el debate: Diabetes en México. Edited by Chapela M. Mexico DF: Universidad Autónoma Metropolitana; 2010:85-110.